臺灣健保癌症用藥事前審查實作指引
1.0.9 - STU1.0.9
臺灣健保癌症用藥事前審查實作指引
1.0.9 - STU1.0.9
This page is part of the 臺灣健保癌症用藥事前審查實作指引(TWPAS IG) (v1.0.9: STU1.0.9) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions
狀態：final
病人狀態評估項目代碼：The common terminology criteria for adverse events(CTCAE) (LOINC + SCT + NHI-健保事前審查-病人狀態評估項目值集 #711434002)
病人狀態評估日期：2025-01-01
評估項目醫事人員身分證號：Practitioner/pra-min
病人狀態評估結果：
CTCAE項目：Hearing impaired (LOINC + SCT + NHI-健保事前審查-病人狀態評估項目值集 #C143528)
value：grade3
CTCAE項目：Peripheral motor neuropathy (LOINC + SCT + NHI-健保事前審查-病人狀態評估項目值集 #C143750)
value：grade4
CTCAE項目：Peripheral sensory neuropathy (LOINC + SCT + NHI-健保事前審查-病人狀態評估項目值集 #C143752)
value：grade5